The year 2022 could be a ripe opportunity for industry to inform public opinion amid sweeping policy changes that stand to transform the global cosmetics sector. Consumers may be inclined to listen when business speaks, but that doesn’t mean they’ll like the conversation.
Here’s the good news: The 2022 Edelman Trust Barometer identifies business as the “only trusted institution” for the second year in a row, scoring above NGOs, government and, in last place, media.
That may not surprise, as it’s business that has delivered COVID-19 vaccines, life-saving treatments and diagnostic tests to a global population sickened, disrupted and
The Washington State Department of Ecology will try to work with companies that violate the Toxic Free Cosmetics Act, rather than reflexively imposing the $5,000-per-violation fine for first-time offenders, says the law’s implementation planner. She noted financial assistance is available for small businesses, as well as incentives for companies adopting measures “beyond compliance.”
US FDA Office of New Drugs Director Peter Stein says review divisions have made the case that a discussion-only meeting would solicit the necessary input.
Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.
